D-Index & Metrics Best Publications

D-Index & Metrics D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines.

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Medicine D-index 83 Citations 20,277 363 World Ranking 10631 National Ranking 116

Overview

What is he best known for?

The fields of study Lars Rejnmark is best known for:

  • Cancer
  • Diabetes mellitus
  • Osteoporosis

His Confidence interval research incorporates elements of Relative risk and Hazard ratio. Lars Rejnmark integrates several fields in his works, including Hazard ratio and Confidence interval. Internal medicine is closely attributed to Risk factor in his study. His studies link Environmental health with Population. His research links Population with Environmental health. His research on Vitamin D and neurology frequently links to adjacent areas such as Endocrinology. His research on Endocrinology frequently links to adjacent areas such as Vitamin D and neurology. His work often combines Surgery and Pediatrics studies. He undertakes interdisciplinary study in the fields of Pediatrics and Surgery through his works.

His most cited work include:

  • Effect of hormone replacement therapy on cardiovascular events in recently postmenopausal women: randomised trial (524 citations)
  • Relative fracture risk in patients with diabetes mellitus, and the impact of insulin and oral antidiabetic medication on relative fracture risk (467 citations)
  • Hypoparathyroidism in the adult: Epidemiology, diagnosis, pathophysiology, target-organ involvement, treatment, and challenges for future research (448 citations)

What are the main themes of his work throughout his whole career to date

His Osteoporosis research also covers Bone mineral and Hip fracture studies. His research combines Endocrinology and Bone mineral. His Endocrinology study frequently draws connections between adjacent fields such as Bone remodeling. While working in this field, Lars Rejnmark studies both Bone remodeling and Osteoporosis. In his research, he performs multidisciplinary study on Internal medicine and Pediatrics. He integrates many fields in his works, including Calcium and Parathyroid hormone. In his articles, he combines various disciplines, including Vitamin D and neurology and vitamin D deficiency. By researching both vitamin D deficiency and Vitamin D and neurology, he produces research that crosses academic boundaries. His research is interdisciplinary, bridging the disciplines of Population and Environmental health.

Lars Rejnmark most often published in these fields:

  • Internal medicine (96.25%)
  • Endocrinology (46.67%)
  • Calcium (36.25%)

What were the highlights of his more recent work (between 2019-2022)?

  • Internal medicine (80.77%)
  • Hypoparathyroidism (38.46%)
  • Calcium (34.62%)

In recent works Lars Rejnmark was focusing on the following fields of study:

His research on Endocrinology often connects related areas such as Vitamin D and neurology and Hypoparathyroidism. His study on Vitamin D and neurology is mostly dedicated to connecting different topics, such as Endocrinology. His Internal medicine study frequently intersects with other fields, such as Disease. He merges many fields, such as Calcium and Parathyroid hormone, in his writings. With his scientific publications, his incorporates both Confidence interval and Hazard ratio. He undertakes interdisciplinary study in the fields of Primary hyperparathyroidism and Hyperparathyroidism through his research. He performs integrative study on Hyperparathyroidism and Parathyroid hormone in his works. His study on Surgery is mostly dedicated to connecting different topics, such as Primary hyperparathyroidism. His Genetics study often links to related topics such as Pregnancy.

Between 2019 and 2022, his most popular works were:

  • Mapping the 3D orientation of nanocrystals and nanostructures in human bone: Indications of novel structural features. (38 citations)
  • European expert consensus on practical management of specific aspects of parathyroid disorders in adults and in pregnancy: recommendations of the ESE Educational Program of Parathyroid Disorders (PARAT 2021) (30 citations)
  • Recommendations for Diagnosis and Treatment of Pseudohypoparathyroidism and Related Disorders: An Updated Practical Tool for Physicians and Patients (28 citations)

In his most recent research, the most cited works focused on:

  • Parathyroid hormone
  • Osteoporosis
  • Diabetes mellitus

His research investigates the connection between Crystallography and topics such as Lamellar structure that intersect with issues in Composite material. His Composite material study often links to related topics such as Lamellar structure. His research on Internal medicine frequently links to adjacent areas such as Confidence interval. His studies link Internal medicine with Confidence interval. Lars Rejnmark integrates several fields in his works, including Pathology and Medical physics. He integrates many fields, such as Medical physics and Pathology, in his works. Lars Rejnmark incorporates Intensive care medicine and Pediatrics in his studies. He undertakes multidisciplinary studies into Pediatrics and Intensive care medicine in his work. His Primary hyperparathyroidism study frequently intersects with other fields, such as Surgery.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

Effect of hormone replacement therapy on cardiovascular events in recently postmenopausal women: randomised trial

Louise Lind Schierbeck;Lars Rejnmark;Charlotte Landbo Tofteng;Lis Stilgren.
BMJ (2012)

772 Citations

Relative fracture risk in patients with diabetes mellitus, and the impact of insulin and oral antidiabetic medication on relative fracture risk

P. Vestergaard;L. Rejnmark;L. Mosekilde.
Diabetologia (2005)

665 Citations

Hypoparathyroidism in the adult: Epidemiology, diagnosis, pathophysiology, target‐organ involvement, treatment, and challenges for future research

John P Bilezikian;Aliya Khan;John T Potts;Maria Luisa Brandi.
Journal of Bone and Mineral Research (2011)

547 Citations

Patient level pooled analysis of 68 500 patients from seven major vitamin D fracture trials in US and Europe

B Abrahamsen;T Masud;A Avenell;F Anderson.
BMJ (2010)

498 Citations

Proton pump inhibitors, histamine H2 receptor antagonists, and other antacid medications and the risk of fracture.

P. Vestergaard;L. Rejnmark;L. Mosekilde.
Calcified Tissue International (2006)

493 Citations

Primary hyperparathyroidism: review and recommendations on evaluation, diagnosis, and management. A Canadian and international consensus.

A A Khan;D A Hanley;R. Rizzoli;J Bollerslev.
Osteoporosis International (2017)

390 Citations

Increased mortality in patients with a hip fracture-effect of pre-morbid conditions and post-fracture complications.

P. Vestergaard;L. Rejnmark;L. Mosekilde.
Osteoporosis International (2007)

379 Citations

Association of vitamin D status with arterial blood pressure and hypertension risk: A mendelian randomisation study

Karani S Vimaleswaran;Karani S Vimaleswaran;Alana Cavadino;Diane J Berry;Rolf Jorde.
The Lancet Diabetes & Endocrinology (2014)

376 Citations

Current issues in the presentation of asymptomatic primary hyperparathyroidism: proceedings of the Fourth International Workshop.

Shonni J. Silverberg;Bart L. Clarke;Munro Peacock;Francisco Bandeira.
The Journal of Clinical Endocrinology and Metabolism (2014)

363 Citations

Fracture rates and risk factors for fractures in patients with spinal cord injury.

P Vestergaard;K Krogh;L Rejnmark;L Mosekilde.
Spinal Cord (1998)

331 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Lars Rejnmark

Peter Vestergaard

Peter Vestergaard

Steno Diabetes Center

Publications: 98

Cyrus Cooper

Cyrus Cooper

University of Southampton

Publications: 91

John P. Bilezikian

John P. Bilezikian

Columbia University

Publications: 77

JoAnn E. Manson

JoAnn E. Manson

Harvard Medical School

Publications: 49

Ian R. Reid

Ian R. Reid

University of Auckland

Publications: 49

William D. Leslie

William D. Leslie

University of Manitoba

Publications: 46

Piet Geusens

Piet Geusens

Maastricht University

Publications: 44

René Rizzoli

René Rizzoli

Geneva College

Publications: 42

Stefan Pilz

Stefan Pilz

Medical University of Graz

Publications: 41

Kim Brixen

Kim Brixen

University of Southern Denmark

Publications: 41

John A. Kanis

John A. Kanis

Australian Catholic University

Publications: 38

Maria Luisa Brandi

Maria Luisa Brandi

University of Florence

Publications: 37

Jonathan D. Adachi

Jonathan D. Adachi

McMaster University

Publications: 32

John A. Eisman

John A. Eisman

Garvan Institute of Medical Research

Publications: 32

Rolf Jorde

Rolf Jorde

University of Tromsø - The Arctic University of Norway

Publications: 31

Jean-Yves Reginster

Jean-Yves Reginster

University of Liège

Publications: 30

Trending Scientists

Roger Feldman

Roger Feldman

University of Minnesota

Wesley W. Chu

Wesley W. Chu

University of California, Los Angeles

Ahmed El-Geneidy

Ahmed El-Geneidy

McGill University

Heinz Egge

Heinz Egge

University of Bonn

D. C. Bassett

D. C. Bassett

University of Reading

Rômulo Romeu Nóbrega Alves

Rômulo Romeu Nóbrega Alves

State University of Paraíba

Patrick A. Jansen

Patrick A. Jansen

Smithsonian Tropical Research Institute

Michael Sulyok

Michael Sulyok

University of Natural Resources and Life Sciences

Tanja Popovic

Tanja Popovic

Centers for Disease Control and Prevention

Casimir A. Fornal

Casimir A. Fornal

Princeton University

David A. Leopold

David A. Leopold

National Institutes of Health

Angela Panoskaltsis-Mortari

Angela Panoskaltsis-Mortari

University of Minnesota

Roland Bammer

Roland Bammer

Monash University

Stephen F. Vatner

Stephen F. Vatner

Rutgers, The State University of New Jersey

Joe Herbert

Joe Herbert

University of Cambridge

Henry C. Kapteyn

Henry C. Kapteyn

University of Colorado Boulder

Something went wrong. Please try again later.